Effect of the combination of topical mepivacaine with total intravenous anesthesia for shared airway surgery in children

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200062233

Enrollment

Unknown

Registered

2022-07-30

Start date

2022-08-01

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway abnormalities

Interventions

Group 1:Mepivacaine

Group 2:Lidocaine

Eligibility

Sex/Gender

All

Age

No minimum to 10 Years

Inclusion criteria

Inclusion criteria: 1. Aged 2 months-10 years; 2. No gender limit; 3. Patients with airway abnormalities required direct laryngobronchoscopy or surgery; 4. ASA I ~ ?; 5. Signing informed consent.

Exclusion criteria

Exclusion criteria: 1. The patient had a history of allergy to the experimental drug; 2. The patient was complicated with arrhythmia or epilepsy.

Design outcomes

Primary

Measure	Time frame
The amount of propofol;	—

Secondary

Measure	Time frame
Heart rate;Oxygen saturation;Systolic blood pressure;Dystolic blood pressure;Bispectral index (BIS) value of EEG;	—

Countries

China

Contacts

Public ContactZhang Ruidong

Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine

doctorruidong@163.com+86 18916637626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026